Digest Network Come funziona
Network
/
Società
Sk
Non verificato

SkylineDx

Di cosa scriviamo

BiologiaFarmaceuticaFitnessSaluteSanità

19 comunicati stampa

Guarda tutti i comunicati
05/11/2026
SkylineDx Wins 2026 BioTech Breakthrough Award for "Diagnostics Company of the Year" for Second Consecutive Year
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
01/07/2026
Salute
Fitness
Medicina - Varie
Scienza
SkylineDx's Merlin CP-GEP Granted FDA Breakthrough Device Designation, Building on Exclusive NCCN Recognition in Melanoma Care
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
12/05/2026
Salute
Fitness
Medicina - Varie
SkylineDx to Showcase New Cutaneous Squamous Cell Carcinoma Findings at 83rd Society for Investigative Dermatology Annual Meeting
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
23/04/2026
Salute
Fitness
Fiere
Eventi
Medicina - Varie
SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
Press Release cover image
25/03/2026
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Merlin CP-GEP™ Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
05/03/2026
Salute
Fitness
Medicina - Varie
Scienza
Ecologia/Salute ambientale
Agricoltura
SkylineDx Launches a Guideline-Informed Risk Assessment Initiative to Support SLNB Decision-Making in Early-Stage Melanoma
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
22/07/2025
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
SkylineDx's Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
08/07/2025
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Independent Meta-Analysis Shows SkylineDx's Merlin CP-GEP Assay Accurately Stratifies Patients for Sentinel Lymph Node Biopsy Selection
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
02/06/2025
Farmaceutica
Sanità
Scienza
SkylineDx Highlights Merlin Assay's Power to Predict Recurrence Risk of Head and Neck Melanoma Without Sentinel lymph node Biopsy at ASCO 2025
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
04/04/2025
Farmaceutica
Sanità
Biologia
SkylineDx Presents Landmark Study on Merlin CP-GEP beyond SLNB prediction: Transforming Melanoma Risk Assessment
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0